ENERGY BOOSTING INTRAMUSCULAR (IM) INJECTION : injection into the muscle
AOD 9604's METAOD Phase II data reported it to be generally well tolerated
Do not touch the cleaned surface after wiping
Choose injectable BPC-157 if: Your target is a tendon, ligament, joint, or muscle injury You need systemic anti-inflammatory or tissue repair effects Speed and reliability of delivery matter You are working within a structured peptide therapy protocol with a licensed provider Choose oral BPC-157 if: Your primary concern is gut health leaky gut, IBD, IBS, gastric ulcers You want high local GI concentrations, not systemic distribution You prefer non-invasive administration for long-term or maintenance use You are combining BPC-157 with another systemic peptide therapy Consider nasal delivery only if: Neurological applications are the clinical focus A licensed provider explicitly recommends it based on your presentation Injection is contraindicated and oral delivery is insufficient Do not choose a delivery method based on convenience alone
PMID: 36268017 J Pharmacol Sci Targeting CD38 to alleviate brain endothelial cell dysfunction and cognitive impairment in vascular dementia
Every production batch is supported by a Certificate of Analysis (COA), RP-HPLC purity testing, LC-MS identity verification, and complete batch traceability to meet the procurement standards of biotechnology companies, universities, pharmaceutical research organizations, contract laboratories, and scientific distributors worldwide